This section of the website is for patients who have been prescribed Cabozantinib Ipsen in the UK. Information for members of the general public can be found here.

Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

Understanding your kidney cancer diagnosis

Renal Cell Carcinoma Video
05:38

Being diagnosed with kidney cancer can raise many questions. This video provides an introduction to renal cell carcinoma (RCC), helping you understand what the kidneys do, how kidney cancer develops, and what your diagnosis means.

In this video, you’ll learn:

  • What the kidneys do and how kidney cancer develop
  • What renal cell carcinoma (RCC) is and the different types of RCC
  • How kidney cancer is staged and what the stages mean
  • How your healthcare team uses staging and risk assessments to guide treatment decisions

DRSC-UK-001042 | September 2026

Understanding your kidney cancer treatment

Renal Cell Carcinoma Video
04:07

This video explains how cabozantinib and nivolumab works. It will help you understand why this treatment has been prescribed, how it works in the body, and what to expect during your treatment journey.

In this video, you’ll learn:
  • Why cabozantinib and nivolumab have been prescribed and how each treatment works
  • How these medicines work together and how they are given
  • What monitoring and follow-up care you can expect

DRSC-UK-001041 | September 2026

What are the side effects of my treatment?

Renal Cell Carcinoma Video
11:39

Starting a new treatment can bring questions and concerns. This video explains some of the common side effects of cabozantinib in combination with nivolumab, how to manage them, and when to contact your healthcare team for support.

In this video, you’ll learn:

  • What side effects you may experience during treatment
  • How to manage some of the side effects
  • When to take medicines to help with the side effects
  • How to look after yourself at home
  • When to contact your medical team for advice

DRSC-UK-001040 | September 2026

Related Content

Explore more Renal Cell Carcinoma Patient Support

Explore more Renal Cell Carcinoma Patient Support

Browse

To access relevant information about Renal Cell Carcinoma, please confirm the following:

Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 
01753 627777.

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.